Biomedicines
Next-Generation SGLT2 Inhibitors: Innovations and Clinical Perspectives.
Dana Movila, Daniel Duda Seiman, Simona Ruxanda Dragan
Published: 202510.3390/biomedicines14010081
Abstract
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have substantially reshaped the management of type 2 diabetes mellitus (T2DM), owing not only to their glucose-lowering properties but also to their consistent cardiovascular and renal protective effe…
Preview only. Read the full abstract at the source